{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:43:43Z","timestamp":1792881823453,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012270","name":"Shaanxi Key Science and Technology Innovation Team Project","doi-asserted-by":"crossref","award":["2018TD-003"],"award-info":[{"award-number":["2018TD-003"]}],"id":[{"id":"10.13039\/501100012270","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Booster Plan of Xijing Hospital","award":["XJZT18ML11"],"award-info":[{"award-number":["XJZT18ML11"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Helicobacter pylori<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">H pylori<\/jats:italic>\n                      ) infection plays a critical role in gastritis-associated diseases, gastroduodenal ulcers, and even gastric cancer. Studies have shown that probiotics may exhibit antagonistic activity against\n                      <jats:italic toggle=\"yes\">H pylori<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This study aimed to assess the efficacy and safety of monotherapy with\n                      <jats:italic toggle=\"yes\">Clostridium butyricum<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">C butyricum)<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Bacillus coagulans (B coagulans)<\/jats:italic>\n                      for\n                      <jats:italic toggle=\"yes\">H pylori<\/jats:italic>\n                      treatment. Our research was an open-label, single-arm pilot study of\n                      <jats:italic toggle=\"yes\">H pylori<\/jats:italic>\n                      eradication. Subjects diagnosed with\n                      <jats:italic toggle=\"yes\">H pylori<\/jats:italic>\n                      infection as outpatients at Xijing Hospital were randomized (1:1:1) to receive 8 weeks of therapy with\n                      <jats:italic toggle=\"yes\">C butyricum<\/jats:italic>\n                      (group A),\n                      <jats:italic toggle=\"yes\">B coagulans<\/jats:italic>\n                      (group B), or\n                      <jats:italic toggle=\"yes\">C butyricum<\/jats:italic>\n                      plus\n                      <jats:italic toggle=\"yes\">B coagulans<\/jats:italic>\n                      (group\u200aC).\n                      <jats:italic toggle=\"yes\">H pylori<\/jats:italic>\n                      status was assessed 1 to 2 weeks after treatment. The\n                      <jats:italic toggle=\"yes\">H pylori<\/jats:italic>\n                      eradication rate according to intention-to-treat and per-protocol analyses was the primary outcome of study, and the delta over baseline score, adverse events, and compliance were the secondary outcomes. This study was registered at ClinicalTrials.gov (NCT 03857425).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 150 subjects were consecutively enrolled from February 2019 to August 2019. The ITT analysis demonstrated that the 3 groups achieved similar eradication rates (18%, 20%, and 26%, respectively,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.597). The PP analysis yielded a similar result (24.3%, 26.3%, and 32.5%, respectively,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a=\u200a.703). None of the subjects reported adverse events during treatment. The 3 groups had comparable compliance rates (74% vs 76% vs 80%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u200a&gt;\u200a.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">C butyricum<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">B coagulans<\/jats:italic>\n                      may effectively inhibit\n                      <jats:italic toggle=\"yes\">H pylori<\/jats:italic>\n                      to some extent, with rare adverse events, and thus may reduce the burden of antibiotic resistance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000022976","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T23:00:32Z","timestamp":1604530832000},"page":"e22976","source":"Crossref","is-referenced-by-count":34,"title":["The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment"],"prefix":"10.1097","volume":"99","author":[{"given":"Jian","family":"Zhang","sequence":"first","affiliation":[{"name":"State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases"},{"name":"Northern theatre air force Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhi","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Xijing Hospital, Air Force Military Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"Xi\u2019an Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Feng","sequence":"additional","affiliation":[{"name":"Xi\u2019an Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"He","sequence":"additional","affiliation":[{"name":"Xi\u2019an Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, Shaanxi Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongquan","family":"Shi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"key":"R1-20230916","article-title":"Schistosomes, liver flukes and Helicobacter pylori","volume":"61","year":"1994","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"key":"R3-20230916","first-page":"8","article-title":"Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group [published correction appears in Gut 1997 Aug;41(2):276]","volume":"41","year":"1997","journal-title":"Gut"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"e12475","DOI":"10.1111\/hel.12475","article-title":"Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection","volume":"23","author":"Liu","year":"2018","journal-title":"Helicobacter"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s11739-013-1013-z","article-title":"Lactobacillus reuteri in the treatment of Helicobacter pylori infection","volume":"9","author":"Dore","year":"2014","journal-title":"Intern Emerg Med"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1136\/gutjnl-2014-307595","article-title":"The stomach in health and disease","volume":"64","author":"Hunt","year":"2015","journal-title":"Gut"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/IDR.S153617","article-title":"Current eradication rate of Helicobacter pylori with clarithromycin-based triple therapy in a gastroenterology practice in the New York metropolitan area","volume":"11","author":"Nayar","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"(3 suppl 2)","key":"R10-20230916","doi-asserted-by":"crossref","first-page":"812S","DOI":"10.1093\/jn\/137.3.812S","article-title":"Helicobacter pylori and probiotics","volume":"137","author":"Lesbros-Pantoflickova","year":"2007","journal-title":"J Nutr"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1345\/aph.1Q104","article-title":"Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori","volume":"45","author":"Wilhelm","year":"2011","journal-title":"Ann Pharmacother"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4291\/wjgp.v5.i4.384","article-title":"Use of probiotics in the fight against Helicobacter pylori","volume":"5","author":"Ruggiero","year":"2014","journal-title":"World J Gastrointest Pathophysiol"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00253-018-09580-3","article-title":"Probiotic therapy in Helicobacter pylori infection: a potential strategy against a serious pathogen?","volume":"103","author":"Qureshi","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3748\/wjg.v24.i1.139","article-title":"Probiotic monotherapy and Helicobacter pylori eradication: a systematic review with pooled-data analysis","volume":"24","author":"Losurdo","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"(2 suppl)","key":"R15-20230916","doi-asserted-by":"crossref","first-page":"444S","DOI":"10.1093\/ajcn\/73.2.444s","article-title":"Probiotics: effects on immunity","volume":"73","author":"Isolauri","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"(suppl 1)","key":"R16-20230916","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/hel.12260","article-title":"Gastric microbiota","volume":"20","author":"Ianiro","year":"2015","journal-title":"Helicobacter"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"G1060","DOI":"10.1152\/ajpgi.00202.2007","article-title":"Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism","volume":"294","author":"Seth","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"G851","DOI":"10.1152\/ajpgi.00327.2009","article-title":"Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier","volume":"298","author":"Karczewski","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"(suppl 1)","key":"R19-20230916","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/hel.12335","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"21","author":"Backert","year":"2016","journal-title":"Helicobacter"},{"key":"R20-20230916","first-page":"141","article-title":"Intestinal pathway of internalisation of lactic acid bacteria and gut mucosal immunostimulation","volume":"13","author":"Perdig\u00f2n","year":"2000","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R21-20230916","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1398-9995.2004.00514.x","article-title":"Probiotics in the treatment of atopic eczema\/dermatitis syndrome in infants: a double-blind placebo-controlled trial","volume":"60","author":"Viljanen","year":"2005","journal-title":"Allergy"},{"key":"R22-20230916","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1574-695X.2002.tb00541.x","article-title":"Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri","volume":"32","author":"Mukai","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"key":"R23-20230916","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000007660","article-title":"Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans","volume":"60","author":"Michetti","year":"1999","journal-title":"Digestion"},{"key":"R24-20230916","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/AEM.70.1.518-526.2004","article-title":"In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota","volume":"70","author":"Sgouras","year":"2004","journal-title":"Appl Environ Microbiol"},{"key":"R25-20230916","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3109\/00365529409096833","article-title":"Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection","volume":"29","author":"Noach","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"R26-20230916","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1651-2227.2005.tb01848.x","article-title":"Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori","volume":"94","author":"Gotteland","year":"2005","journal-title":"Acta Paediatr"},{"key":"R27-20230916","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1523-5378.2009.00675.x","article-title":"Long-term administration of probiotics to asymptomatic pre-school children for either the eradication or the prevention of Helicobacter pylori infection","volume":"14","author":"Boonyaritichaikij","year":"2009","journal-title":"Helicobacter"},{"key":"R28-20230916","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2036.2003.01675.x","article-title":"Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis","volume":"18","author":"Pantoflickova","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R29-20230916","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1523-5378.2008.00593.x","article-title":"Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study","volume":"13","author":"Francavilla","year":"2008","journal-title":"Helicobacter"},{"key":"R30-20230916","first-page":"737","article-title":"Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori","volume":"80","author":"Wang","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"R31-20230916","doi-asserted-by":"crossref","first-page":"e3768","DOI":"10.5812\/ijp.3768","article-title":"Saccharomyces boulardii in Helicobacter pylori eradication in children: a randomized trial from Iran","volume":"26","author":"Namkin","year":"2016","journal-title":"Iran J Pediatr"},{"key":"R32-20230916","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1473-3099(19)30272-5","article-title":"Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial","volume":"19","author":"Liou","year":"2019","journal-title":"Lancet Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022976","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:50:13Z","timestamp":1694814613000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022976"}},"subtitle":["An open-label, single-arm pilot study"],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":32,"journal-issue":{"issue":"45","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022976","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,6]]}}}